{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T10:26:10Z","timestamp":1694168770898},"reference-count":30,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.6310","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T11:07:21Z","timestamp":1528888041000},"source":"Crossref","is-referenced-by-count":2,"title":["Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease"],"prefix":"10.3892","author":[{"given":"Bing","family":"Han","sequence":"first","affiliation":[{"name":"The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, The State and Shandong Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingli","family":"Wang","sequence":"additional","affiliation":[{"name":"Internal Medicine Cardiovascular Department, The Sixth People's Hospital of Jinan, Jinan, Shandong 250200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"key20200713114116_b1-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: A community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key20200713114116_b2-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: A comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"key20200713114116_b3-etm-0-0-6310","article-title":"Applied research of specific phosphodiesterase inhibitor during perioperative period of rheumatic valvular disease combining with pulmonary hypertension (unpublished PhD thesis)","author":"Guo","year":"2012","journal-title":"Southern Medical University"},{"key":"key20200713114116_b4-etm-0-0-6310","first-page":"469","article-title":"Effect of milrinone on pulmonary function and dynamics of congenital heart disease with pulmonary hypertension in patients with pulmonary oxygen","volume":"28","author":"Yu","year":"2012","journal-title":"J Practical Med"},{"key":"key20200713114116_b5-etm-0-0-6310","first-page":"200","article-title":"Effect of milrinone on pulmonary hypertension after cardiac surgery","volume":"11","author":"Xu","year":"2013","journal-title":"Guide Chin Med"},{"key":"key20200713114116_b6-etm-0-0-6310","first-page":"49","article-title":"The protective effect of milrinone on heart function in plateau region in children with congenital heart disease and pulmonary hypertension after operation","volume":"54","author":"Yao","year":"2014","journal-title":"Shandong Med J"},{"key":"key20200713114116_b7-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International society of heart and lung transplantation (ISHLT)","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"key20200713114116_b8-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/01.CIR.70.4.657","article-title":"Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation","volume":"70","author":"Yock","year":"1984","journal-title":"Circulation"},{"key":"key20200713114116_b9-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1086\/681264","article-title":"Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers","volume":"5","author":"Trammell","year":"2015","journal-title":"Pulm Circ"},{"key":"key20200713114116_b10-etm-0-0-6310","first-page":"319","article-title":"The clinical efficacy and safety of oral administration of atorvastatin in patients with pulmonary hypertension with left heart disease","volume":"37","author":"Li","year":"2015","journal-title":"Ningxia Med J"},{"key":"key20200713114116_b11-etm-0-0-6310","first-page":"14","article-title":"Efficacy of levosimendan combined with sildenafil in the treatment of chronic heart failure with pulmonary hypertension","volume":"40","author":"Lian","year":"2013","journal-title":"Practical J"},{"key":"key20200713114116_b12-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0002-9629(15)41723-9","article-title":"Milrilone: Basic and clinical pharmacology and acute and chronic management","volume":"311","author":"Shipley","year":"1996","journal-title":"Am J Med Sci"},{"key":"key20200713114116_b13-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/BF00174752","article-title":"Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai","volume":"344","author":"Schudt","year":"1991","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key20200713114116_b14-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jss.2006.05.038","article-title":"Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone","volume":"136","author":"Kume","year":"2006","journal-title":"J Surg Res"},{"key":"key20200713114116_b15-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00024382-199405000-00011","article-title":"Amrinone suppresses the synthesis of tumor necrosis factor-alpha in human mononuclear cells","volume":"1","author":"Endres","year":"1994","journal-title":"Shock"},{"key":"key20200713114116_b16-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1253\/jcj.65.858","article-title":"Randomized trial of phosphodiesterase inhibitors versus catecholamines in patient with acutely decompensated heart failure","volume":"65","author":"Kawamura","year":"2001","journal-title":"Jpn Circ J"},{"key":"key20200713114116_b17-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1479-5876-7-67","article-title":"Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure","volume":"29","author":"Lanfear","year":"2009","journal-title":"J Transl Med"},{"key":"key20200713114116_b18-etm-0-0-6310","first-page":"H370","article-title":"Adenosine 3\u2032,5\u2032-cyclic monophosphate attenuates neutrophil-mediated increase in endothelial permeability","volume":"264","author":"Siflinger-Bimboim","year":"1993","journal-title":"Am J Physiol"},{"key":"key20200713114116_b19-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1161\/CIRCULATIONAHA.108.790162","article-title":"Milrinone use is associated with post-operative atrial fibrillation after cardiac surgery","volume":"118","author":"Fleming","year":"2008","journal-title":"Circulation"},{"key":"key20200713114116_b20-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jtcvs.2004.09.011","article-title":"Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopumonary bypass","volume":"130","author":"Lamarche","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20200713114116_b21-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1067\/mje.2002.118526","article-title":"Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease","volume":"15","author":"Burgess","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"key20200713114116_b22-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"e0129557","DOI":"10.1371\/journal.pone.0129557","article-title":"Real-time three-dimensional echocardiography to assess right ventricle function in patients with pulmonary hypertension","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"key20200713114116_b23-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"key20200713114116_b24-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"e94263","DOI":"10.1371\/journal.pone.0094263","article-title":"N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency","volume":"9","author":"Harbaum","year":"2014","journal-title":"PLoS One"},{"key":"key20200713114116_b25-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.amjcard.2006.02.061","article-title":"N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension","volume":"98","author":"Andreassen","year":"2006","journal-title":"Am J Cardiol"},{"key":"key20200713114116_b26-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00408-015-9802-y","article-title":"MR-proADM predicts exercise capacity and survival superior to other biomarkers in PH","volume":"193","author":"Kolditz","year":"2015","journal-title":"Lung"},{"key":"key20200713114116_b27-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1213\/ane.0b013e3181981fbe","article-title":"The effect of milrinone on platelet activation as determined by TEG platelet mapping","volume":"108","author":"Wesley","year":"2009","journal-title":"Anesth Analg"},{"key":"key20200713114116_b28-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1213\/00000539-199507000-00009","article-title":"The effects of milrinone on platelets in patients undergoing cardiac surgery","volume":"81","author":"Kikura","year":"1995","journal-title":"Anesth Analg"},{"key":"key20200713114116_b29-etm-0-0-6310","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1067\/mhj.2001.111404","article-title":"Pharmacodynamic effects of milrinone with and without a bolus loading infusion","volume":"141","author":"Baruch","year":"2001","journal-title":"Am Heart J"},{"key":"key20200713114116_b30-etm-0-0-6310","first-page":"111","article-title":"Clinical study of milrinone in the treatment of neonatal persistent pulmonary hypertension","volume":"8","author":"Huang","year":"2012","journal-title":"Straits Sci"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T10:41:23Z","timestamp":1594636883000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.6310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.6310","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]}}}